Related Experiment Video
Updated: May 18, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
[Lung cancer - on the way to a molecular classification]
1Institut für Pathologie, Universitätsspital Basel.
Abstract:
Treatment options for patients with advanced lung cancer have greatly improved in recent years. New molecular-targeted drugs are avaliable based on predictive biomarkers. Molecular diagnostics are key to successful therapy. Guidelines and recommendations for lung cancer testing and treatment are evolving, and it is increasingly challenging to stay up-to-date. In view of the rapid development in the lung cancer field, the current article discusses the current evidence for lung cancer classification and testing, and illustrates new perspectives in modern oncology.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
lncRNA - Long Non-coding RNAs
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
